Studies from the early 2000s demonstrated that ER regulates hundreds to thousands of genes in breast cancer [37,38], and genome-wide binding-site studies pioneered by Myles Brown’s laboratory revealed that many ER enhancers were located far away from the genes they regulated [39]. This evidence concerns the gene ESR1 and breast cancer.